Question 1

What is the catalog number for Tissue Genomic DNA, Omentum?

Accepted Answer

The catalog number for Tissue Genomic DNA, Omentum is CD563198.

Question 2

What sizes are available for Tissue Genomic DNA, Omentum?

Accepted Answer

Tissue Genomic DNA, Omentum is available in the following size(s): 5 µg.

Question 3

Is Tissue Genomic DNA, Omentum in stock?

Accepted Answer

Tissue Genomic DNA, Omentum is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Where can I find the safety data sheet (SDS/MSDS) for Tissue Genomic DNA, Omentum?

Accepted Answer

The safety data sheet for Tissue Genomic DNA, Omentum is available here: https://cdn.origene.com/sds/cd563198.pdf.

Question 5

What is Tissue Genomic DNA, Omentum used for?

Accepted Answer

DNA (5 µg); Omentum; Inflammation of omentum, chronic

Question 6

What host species was used to raise this antibody?

Accepted Answer

The host species used in production is listed under product specifications on the datasheet, and is relevant when selecting a compatible secondary antibody for your assay.

Question 7

What is the difference between this product and a similar catalogue number?

Accepted Answer

Differences typically involve clone, conjugate, host species, or validated applications. Compare the respective datasheets, or contact us with both catalogue numbers for a direct comparison.

Question 8

Do you offer custom or private-label production of this type of product?

Accepted Answer

Yes, custom antibody development and private-label production services are available. Contact our sales team to discuss your target, timeline, and quantity requirements.

Tissue Genomic DNA, Omentum

Product Specifications

Stability

Storage Conditions

Frequently Asked Questions

Explore Other Products

Human GOLGA8J activation kit by CRISPRa

Angiotensin II Type 1 Receptor (AGTR1) Rabbit Polyclonal Antibody

FOLH1 / PSMA (Prostate Epithelial Marker) (FOLH1/2354), CF405S conjugate, 0.1mg/mL

Frozen Tissue Sections, Prostate

ERCC1 / RAD10 (Tumor Progression Marker) (ERCC1/2318), CF568 conjugate, 0.1mg/mL

CD63 (NKI-C3), 0.2mg/mL